ALT Q2 2017 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4,938-99.8% YoY

Gross Profit

-$5M-106314.1% margin

Operating Income

-$4M-81232.6% margin

Net Income

-$3M-62988.7% margin

EPS (Diluted)

$-7.62

QoQ Revenue Growth

-99.4%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$617,908

Balance Sheet

Total Assets

$91M

Total Liabilities

$15M

Stockholders' Equity

$76M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4,938	$2M	-99.8%
Gross Profit	-$5M	$729,741	-819.4%
Operating Income	-$4M	-$507,744	-690.0%
Net Income	-$3M	$8M	-138.7%